Research Site

Meriden, Connecticut

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
mi
from
Meriden, CT
Click here to add this to my saved trials